IgG Fusion Proteins for Brain Delivery of Biologics via Blood-Brain Barrier Receptor-Mediated Transport

By rosaguerrero • July 28, 2022

Boado RJ. IgG Fusion Proteins for Brain Delivery of Biologics via Blood-Brain Barrier Receptor-Mediated Transport. Pharmaceutics. 2022 Jul 15;14(7):1476. doi: 10.3390/pharmaceutics14071476. PMID: 35890374; PMCID: PMC9322584.

Tags: Alzheimer’s disease, blood–brain barrier, decoy receptors, fusion proteins, insulin receptor, lysosomal storage disorders, monoclonal antibody, neurotrophic factors, Parkinson’s disease, protein-based therapy, Publications, transferrin receptor

Toward Providing Equitable Care for Adults with Congenital Heart Disease: Where We Are and Where We Need to Be

Lin JP, Marelli A, Liu A, Guo L, Desalvo J, Hile D, Roeder M, Aboulhosn J, Daniels CJ. Toward Providing Equitable Care for Adults with[...]

Consensus Recommendations from the 2024 International Follicular Lymphoma Scientific Workshop

Merryman RW, Rutherford SC, Ansell SM, Armand P, Leonard JP, Nastoupil L, Smith SM, Timmerman JM, Zelenetz AD, Gutierrez M, Béguelin W, Casulo C, Cerhan[...]

Development and validation of a bronchoalveolar lavage genomic classifier for acute cellular rejection

Weigt SS, Zhou J, Okuno T, Neely ML, Lari S, Palchevskiy V, Todd JL, Snyder LD, Sayah D, Shino MY, Reynolds J, Shah PD, Singer[...]